Symetryx Corp

All filings by Symetryx Corp on record concern Ohr Pharmaceutical Inc. Between 1 September 2023 and 18 September 2023, the trades on record add up to 7 filings.

The open-market side counts 1 purchase for €55k alongside 6 sales for €668k. On balance, insiders were net sellers of €612k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

The latest filing, published on 18 September 2023, reports an open-market sale of €122k in Ohr Pharmaceutical Inc. The latest purchase dates back some time: it was published 1,143 days ago, on 7 September 2023. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.